These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 4222477)

  • 21. The mechanism of activation of cat plasma by streptokinase.
    Mootse G; Fleming LB; Cliffton EE
    Thromb Diath Haemorrh; 1965 Nov; 14(3-4):562-79. PubMed ID: 5865611
    [No Abstract]   [Full Text] [Related]  

  • 22. Differences between neonates and adults in plasmin inhibitory and antifibrinolytic action of aprotinin.
    Zenker M; Ries M
    Thromb Res; 2002 Jul; 107(1-2):17-21. PubMed ID: 12413584
    [No Abstract]   [Full Text] [Related]  

  • 23. Magnetoelastic transducers for monitoring coagulation, clot inhibition, and fibrinolysis.
    Puckett LG; Lewis JK; Urbas A; Cui X; Gao D; Bachas LG
    Biosens Bioelectron; 2005 Mar; 20(9):1737-43. PubMed ID: 15681188
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Lysis of thrombi and emboli by means of streptokinase. I. Activation of fibrinolysis, mechanism of plasmin activity, indications and contra-indications, treatment principles].
    Janda R; Cencora A; Uzieblo W
    Przegl Lek; 1969; 25(10):701-5. PubMed ID: 4242965
    [No Abstract]   [Full Text] [Related]  

  • 25. [COMPARATIVE STUDIES ON THE EFFECT OF STREPTOKINASE AND STREPTOKINASE-ACTIVATED PLASMINOGEN IN THROMBOLYTIC THERAPY].
    DEUTSCH E; STACHER A
    Wien Klin Wochenschr; 1963 Sep; 75():667-70. PubMed ID: 14059190
    [No Abstract]   [Full Text] [Related]  

  • 26. [On the problem of artificial activation of the fibrinolytic system. Studies on spontaneously activated human plasmin on the dependence of activator formation on the quantity of streptokinase supplement].
    AUERSWALD W; DOLESCHEL W
    Wien Klin Wochenschr; 1961 Jun; 73():463-6. PubMed ID: 13685089
    [No Abstract]   [Full Text] [Related]  

  • 27. [Origin and physiological significance of "activated" plasminogen and plasmin for the mobilization of the anticoagulation system].
    Kudrjaschow BA; Liapina LA
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1972; 98(3):313-21. PubMed ID: 4123095
    [No Abstract]   [Full Text] [Related]  

  • 28. [Resistance index of fibrinolysis (RIF)].
    Paleirac G; Kahn P
    Hemostase; 1965 Sep; 5(3):317-9. PubMed ID: 5856893
    [No Abstract]   [Full Text] [Related]  

  • 29. [The fibrinolytic activity in Seegers' cattle prothrombin preparations. A contribution to the problem of the activation of cattle prothrombin by plasmin].
    Andrassy K; Egbring R; Egli H
    Thromb Diath Haemorrh; 1969 Nov; 22(2):377-90. PubMed ID: 4245334
    [No Abstract]   [Full Text] [Related]  

  • 30. Textilinin-1, an alternative anti-bleeding agent to aprotinin: Importance of plasmin inhibition in controlling blood loss.
    Flight SM; Johnson LA; Du QS; Warner RL; Trabi M; Gaffney PJ; Lavin MF; de Jersey J; Masci PP
    Br J Haematol; 2009 Apr; 145(2):207-11. PubMed ID: 19236611
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Studies on the mechanisms of action of aprotinin and tranexamic acid as plasmin inhibitors and antifibrinolytic agents.
    Longstaff C
    Blood Coagul Fibrinolysis; 1994 Aug; 5(4):537-42. PubMed ID: 7531000
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Proposal of a modification of the thromboelastographic method for the study of fibrinolysis activated with streptokinase].
    CACCIOLA E; FICHERA C; FERRAUTO A
    Boll Soc Ital Biol Sper; 1960 Dec; 36():1307-10. PubMed ID: 13689689
    [No Abstract]   [Full Text] [Related]  

  • 33. [Inhibition of plasmin system by 4-(2-carboxyethyl) phenyl-trans-4-aminomethyl cyclohexane carboxylate hydrochloride (DV 1006) (AUTHOR'S TRANSL)].
    Maki M
    Rinsho Ketsueki; 1972 Feb; 13(1):30-7. PubMed ID: 4281839
    [No Abstract]   [Full Text] [Related]  

  • 34. [Experiences with therapeutic fibrinolysis by streptokinase].
    FISCHBACHER W
    Schweiz Med Wochenschr; 1960 Oct; 90():1241-3. PubMed ID: 13699798
    [No Abstract]   [Full Text] [Related]  

  • 35. [The behavior of plasmatic fibrinogenolytic activity after activation with streptokinase and urokinase in presence of epsilon amino-caproic acid and of the parotid inhibitor of trypsin].
    Ferrauto A; Cristaldi R; Terranova R; Giuffrida G
    Boll Soc Ital Biol Sper; 1965 Dec; 41(24):1486-7. PubMed ID: 5298373
    [No Abstract]   [Full Text] [Related]  

  • 36. [Inhibition of esterase by L-lysine, the activator and fibrinolytic activity of the plasmin-streptokinase activator complex].
    Aĭsina RB; Gaĭsarian ES; Snitko IaE; Varfolomeev SD
    Bioorg Khim; 1994 Feb; 20(2):182-9. PubMed ID: 8155080
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [On the systemic effect of orally administered bromelin].
    Lang H; Helger R; Lücker P; Breddin K; Hausamen TU; Rick W
    Arzneimittelforschung; 1969 Jun; 19(6):939-44. PubMed ID: 5306618
    [No Abstract]   [Full Text] [Related]  

  • 38. The effect of fibrinolysis inhibitors on the ellagic acid activation of Hageman factor in the dog.
    Girolami A; Fioretti D; Cella G; Pedrazzoli G; Bernardi R
    Thromb Diath Haemorrh; 1971 Dec; 26(3):553-64. PubMed ID: 5316937
    [No Abstract]   [Full Text] [Related]  

  • 39. Studies on hyaline membrane disease. I. The fibrinolysin system in pathogenesis and therapy.
    AMBRUS CM; WEINTRAUB DH; DUNPHY D; DOWD JE; PICKREN JW; NISWANDER KR; AMBRUS JL
    Pediatrics; 1963 Jul; 32():10-24. PubMed ID: 14012535
    [No Abstract]   [Full Text] [Related]  

  • 40. A comparative study of fibrinolytic activity in human, rat, rabbit, and dog blood.
    Hedlin AM; Monkhouse FC; Milojevic SM
    Can J Physiol Pharmacol; 1972 Jan; 50(1):11-6. PubMed ID: 4257760
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.